CRO Services (Phase 1-3) Partners
Clinical Trials are required for drug therapies to receive regulatory approval.
A Phase 1 trial is the first to involve human subjects, and their objective is to determine the highest dose of a treatment that can be safely administered to patients. A Phase 2 trial is conducted on a small number of patients to determine if the drug is effective. If the Phase 1 and Phase 2 trials are successful, a larger Phase 3 trial is conducted to gather data to present to the FDA. In a Phase 3 trial a drug is often tested against a placebo or the current standard of care. Clinical trials are expensive and time consuming, and they require expertise in many areas. Sponsors need to perform study startup (which includes site selection and patient recruitment), manage and oversee the trial, and collect and analyze trial data. All of these operations can be performed by a CRO.
How can we help?
Looking for help with your Phase 1-3 project? If you're searching for information or a supplier, let Clinical Leader lend you a hand.
Altasciences
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services.
Avance Clinical
Avance Clinical specializes in world-class operations, providing biotechs with strategic guidance from their pre-clinical development to Phase I early phase with our experienced ClinicReady team through to Phase II to III late-phase studies, supported by our proven GlobalReady team. Our focus and approach is one that is dedicated to biotechs who require a CRO partner that delivers fast, agile, and adaptive operations. We understand how critical it is to biotechs that we offer high quality, solution-oriented and innovative project delivery teams to work on their projects. In parallel, we offer a cost-effective model that ensures rapid delivery of results with robust, globally accepted data.
Capabilities
ClinAI
ClinAI is an end-to-end platform that transforms vendor selection and oversight in clinical trials with intelligent analytics. It streamlines custom RFP creation, enables true apples-to-apples comparisons, tracks scope changes, manages budgets and invoices, and generates audit-ready documentation. Built by clinical operations experts, ClinAI replaces emails and spreadsheets with a secure, centralized system that accelerates decisions, reduces costs, and delivers clearer insights.
Capabilities
Have questions about selecting the right Phase 1-3 service provider?
The Clinical Leader team can help. We'll match your needs with the right companies.
Contact us via email for assistance.
Dash Bio
Dash Bio is a CRO on a mission to accelerate the process by which drugs are developed. Traditional bioanalysis is slow, manual, and error-prone. Dash changes the equation as the only tech-first bioanalysis partner, putting both speed and quality at the forefront. Processing every sample on an automated platform, they eliminate variability and delays, delivering high quality, GLP-compliant results for preclinical and clinical studies in days, not months.
Capabilities
Dr. Vince Clinical Research
Dr. Vince Clinical Research (DVCR) is a full-service CRO specializing in early phase trials in both healthy normal volunteers and patient populations across a wide range of trial designs and therapeutic areas such as neuroscience, substance use disorders, dermatology, immunology, cardiometabolic disorders and many others. CRO services include project management, data management, biostatistics, statistical programming, PK/PD analysis and modeling, clinical and medical monitoring, medical writing as well as site feasibility, management and central laboratory services for Phase I-II multi-site trials with our global network of site partners.
Capabilities
Ergomed Clinical Research
Ergomed is a global leader in delivering specialized services in oncology, rare disease, and complex trials to the pharmaceutical and biotech sectors. Our comprehensive support covers the entire clinical trial process, from early phase to post-approval, offering full-service, industry-leading clinical trial management solutions as a trusted partner.
Capabilities
inSeption Group
inSeption Group delivers full-service outsourcing, functional service provider solutions, and strategic consulting, with deep expertise in oncology, hematology, neurodegenerative disorders, rare diseases, and cell and gene therapy. By integrating dedicated industry experts who treat your assets with the same care and commitment as you do, we ensure exceptional execution, seamless continuity, and results that truly stand apart.
Capabilities
IQVIA Biotech
IQVIA Biotech delivers flexible clinical development solutions designed to help biotech and emerging biopharma companies get treatments to patients. When you partner with our clinical team, you gain expertise from two decades of running clinical trials exclusively for biotech companies. We understand the unique challenges, hurdles, and opportunities you face. From strategy and trial design to execution, we draw on this experience to put together the right solution for you.
Capabilities
Parexel
Parexel is a leading global clinical development partner providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’s most complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process.
Capabilities
Quotient Sciences
Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services across the entire development pathway for small molecule & peptide drug programs. Cutting through silos across a range of drug development capabilities, we save precious time and money in getting drugs to patients.
Capabilities
Thermo Fisher Scientific
The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, enables customers to accelerate innovation and increase drug development productivity. Utilizing patient-centered strategies and data analytics, our capabilities cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, novel approaches to patient recruitment and investigator sites, and comprehensive laboratory services.
Thermo Fisher Scientific
Thermo Fisher Scientific delivers end-to-end pharma services spanning drug development, clinical trial logistics, and commercial manufacturing. As a trusted CDMO, we support pharmaceutical, biotech, and life sciences companies through every stage, from API and biologics to cell therapy, mRNA, packaging, and logistics. With more than 60 global facilities and expert teams across four continents, we provide tailored solutions that accelerate development and speed medicines to patients.
Capabilities
Veristat
Veristat, the Science-First™ full service CRO and consultancy, enables sponsors to solve the unique and complex challenges associated with accelerating therapies through clinical development onto regulatory approval and post-marketing. With our focus on novel drug development and 30 years of experience in clinical trial planning and execution, we deliver bold approaches that make the impossible possible.
Capabilities
Worldwide Flex
Worldwide Flex is a trusted functional service provider (FSP) and resourcing partner for clinical trials. We deliver best-in-class functional outsourcing services through a variety of models. Whether delivering one function or many, a specialized resource or a tailored team, Worldwide Flex does more than fill a functional need for you. With expertise spanning clinical operations, data management, biostatistics and programming, safety, and medical writing, our clinical research professionals bring added value at every stage.
Capabilities
Worldwide Oncology
Worldwide Clinical Trials (Worldwide) is a global CRO serving development-driven biopharmaceutical companies, with more than 4,400 professionals operating across more than 70 countries. The company delivers therapeutically dedicated expertise in neuroscience, oncology, rare disease, and internal medicine, with comprehensive support across every development phase – from early-stage and first-in-human studies through Phase III registration trials.
Capabilities